These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8646434)
21. Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. Dawson JK; Graham DR; Desmond J; Fewins HE; Lynch MP Rheumatology (Oxford); 2002 Mar; 41(3):262-7. PubMed ID: 11934961 [TBL] [Abstract][Full Text] [Related]
22. [Weekly low-dose methotrexate in rheumatoid arthritis. Review of the literature]. Manganelli P; Troise Rioda W Minerva Med; 1993 Oct; 84(10):541-52. PubMed ID: 8247309 [TBL] [Abstract][Full Text] [Related]
23. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Kaneko Y; Suwa A; Ikeda Y; Hirakata M Mod Rheumatol; 2006; 16(1):36-8. PubMed ID: 16622722 [TBL] [Abstract][Full Text] [Related]
24. [Respiratory complications of new treatments for rheumatoid arthritis]. Lioté H Rev Mal Respir; 2004 Dec; 21(6 Pt 1):1107-15. PubMed ID: 15767955 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort. Müller RB; von Kempis J; Haile SR; Schiff MH Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697 [TBL] [Abstract][Full Text] [Related]
26. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
27. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ Arthritis Rheumatol; 2014 Apr; 66(4):803-12. PubMed ID: 24757133 [TBL] [Abstract][Full Text] [Related]
28. Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire). Fatimah N; Salim B; Nasim A; Hussain K; Gul H; Niazi S Clin Rheumatol; 2016 May; 35(5):1341-5. PubMed ID: 27053094 [TBL] [Abstract][Full Text] [Related]
34. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region. Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474 [TBL] [Abstract][Full Text] [Related]
35. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment. Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184 [TBL] [Abstract][Full Text] [Related]
36. Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study. Branco JC; Barcelos A; de Araújo FP; Sequeira G; Cunha I; Patto JV; Oliveira M; Mateus MP; Couto M; Nero P; Pinto P; Monteiro P; Castelão W; Félix J; Ferreira D; Almeida J; Silva MJ Adv Ther; 2016 Jan; 33(1):46-57. PubMed ID: 26724937 [TBL] [Abstract][Full Text] [Related]
37. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity. Borman P; Taşbaş Ö; Karabulut H; Tukun A; Yorgancıoğlu R Rev Bras Reumatol; 2015; 55(6):485-92. PubMed ID: 25687398 [TBL] [Abstract][Full Text] [Related]
38. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. Golden MR; Katz RS; Balk RA; Golden HE J Rheumatol; 1995 Jun; 22(6):1043-7. PubMed ID: 7674228 [TBL] [Abstract][Full Text] [Related]
39. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005 [TBL] [Abstract][Full Text] [Related]
40. Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. Cron RQ; Sherry DD; Wallace CA J Pediatr; 1998 May; 132(5):901-2. PubMed ID: 9602213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]